EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized Lesions

Enhancer of zeste homolog 2 (EZH2) and Bcl-2 gene rearrangement or protein upregulation played pivotal roles in the carcinogenesis of various malignancies including lymphomas. However, EZH2/Bcl-2 expression pattern and its clinicopathologic/prognostic significance in diffuse large B-cell lymphoma (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yujie, Chen, Xiaohui, Huang, Chuanzhong, Chen, Gang, Chen, Fangfang, Lu, Jianping, Shi, Xi, He, Cheng, Zeng, Zhiyong, Qiu, Yanhua, Chen, Junqiang, Lin, Rongbo, Chen, Yanping, Chen, Junmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548167/
https://www.ncbi.nlm.nih.gov/pubmed/31205561
http://dx.doi.org/10.7150/jca.29807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548167/
https://www.ncbi.nlm.nih.gov/pubmed/31205561
http://dx.doi.org/10.7150/jca.29807

Ejemplares similares